Background Pain after therapy is an important clinical problem in patients with breast cancer. Unfortunately, cancer patients have a lower quality of life due to inadequate treatment of posttreatment pain; therefore, improving medication management plans and palliative care has become one of the most...
sex (not considered for breast cancer medications). age at treatment initiation: age when the first purchase was recorded. secondary prevention: whether the treatment was started after a major event related to the medication considered. The following diagnosis (ICD-10 codes) were considered: statins...
Current BMA prescription trends in breast and prostate cancer with bone metastases, have advocated the de-escalation of antiresorptive therapy usually two years after cancer treatment. This step towards reducing the administration of antiresorptive drugs has been shown to be safe, and does not change...
12 Given that these studies focused on treatment of women with breast cancer or DCIS and were often conducted in comparison with tamoxifen rather than placebo, it is unclear whether these findings are generalizable to a primary prevention population. Estimate of Magnitude of Net Benefit Whether risk...
It is not known if LIBTAYO passes into your breast milk. Do not breastfeed during treatment and for at least 4 months after the last dose of LIBTAYO. Tell your healthcare provider about all the medicines you take, including prescription and over-the- counter medicines, vitamins, and herbal ...
To assess the impact of patient–provider communication on adherence to tamoxifen (TAM) and aromatase inhibitors (AIs) 36months after breast cancer (BC) di... Y Liu,JL Malin,AL Diamant,... - 《Breast Cancer Research & Treatment》 被引量: 58发表: 2013年 Adjuvant endocrine therapy initiation...
cancer of another site (non-breast) in the definition. The occurrence of any of loco-regional recurrence, distant recurrence, or contralateral recurrence, was identified based on (i) the resumption of radiotherapy, chemotherapy, or targeted therapy at least 6 months after the end of the initial...
cIntended treatment duration is 5 years or until a breast, neoplastic, cardiovascular, or toxicity event. Table 1. Breast Cancer Risk Assessment Methods (Key Question 1) View LargeDownload Table 2. Randomized Clinical Trials of Medications to Reduce Risk for Breast Cancer (KQ2, KQ3, KQ4) Vie...
First, the medication was investigated at the time of admission to the hospital for assessing the risks of long-term medication which patients received before the start of treatment. Second, after the start of cancer treatment, the medication was analyzed including antineoplastic agents and supportive...
BAVENCIO may be used: o as maintenance treatment when your cancer has responded or stabilized after you have received platinum-containing chemotherapy as your first treatment. o when you have received platinum-containing chemotherapy, and it did not work or is no longer working. • a type of ...